Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Study Comparing Two Different Conditioning Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Children With Juvenile Myelomonocytic Leukemia (JMML)
Conditions
Interventions
Allogeneic Hematopoietic Stem Cell Transplantation
Busulfan
+7 more
Locations
50
United States
Children's Hospital of Alabama
Birmingham, Alabama, United States
Phoenix Childrens Hospital
Phoenix, Arizona, United States
City of Hope Comprehensive Cancer Center
Duarte, California, United States
Mattel Children's Hospital UCLA
Los Angeles, California, United States
Children's Hospital of Orange County
Orange, California, United States
Rady Children's Hospital - San Diego
San Diego, California, United States
Start Date
June 24, 2013
Primary Completion Date
December 31, 2017
Completion Date
December 31, 2017
Last Updated
December 5, 2018
NCT04726241
NCT05735717
NCT06247787
NCT03314974
NCT05800210
NCT03190915
Lead Sponsor
Children's Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions